☰
HomeLiving Beyond BordersGZERO WorldSignalIn 60 SecondsPuppet RegimeGZERO World PodcastContact UsAbout UsCareersPrivacy PolicyTerms

Microsoft's big-name hire

March 19, 2024
Scott Nover
​Mustafa Suleyman CEO and co-founder of Inflection AI speaks during the Axios BFD event in New York City, U.S., October 12, 2023.
Mustafa Suleyman CEO and co-founder of Inflection AI speaks during the Axios BFD event in New York City, U.S., October 12, 2023.
REUTERS/Brendan McDermid

What a splash! Microsoft announced earlier today that it has hired one of the most prominent figures in the AI revolution: Mustafa Suleyman. Suleyman co-founded the British AI research lab DeepMind, which Google acquired for £400 million in 2014 (~$656 million).

Suleyman will run a new division called Microsoft AI, overseeing its Copilot and Bing products, among others. Microsoft has become a major player in generative AI through its $13 billion investment in ChatGPT-maker OpenAI, whose deep-learning language models now fuel Microsoft's own AI offerings. He will focus on advancing consumer products — in other words, getting you to use this cutting-edge tech.

More from GZERO Media

Mining for peace: can a US-brokered deal end the conflict in the DRC?

U.S. President Donald Trump speaks with Democratic Republic of the Congo's Foreign Minister Therese Kayikwamba Wagner and Rwanda's Foreign Minister Olivier Nduhungirehe on June 27, 2025.
REUTERS

On June 27, the Democratic Republic of Congo and Rwanda signed a US-mediated peace accord in Washington, D.C., to end decades of violence in the DRC’s resource-rich Great Lakes region. The agreement commits both nations to cease hostilities, withdraw troops, and to end support for armed groups operating in eastern Congowithin 90 days.

Why life sciences are critical to national security

What if the next virus isn’t natural, but deliberately engineered and used as a weapon? As geopolitical tensions rise and biological threats become more complex, health security and life sciences are emerging as critical pillars of national defense. In the premiere episode of “The Ripple Effect: Investing in Life Sciences”, leading experts explore the dual-use nature of biotechnology and the urgent need for international oversight, genetic attribution standards, and robust viral surveillance.

About UsCareers PressContact Us Privacy PolicyTerms of Use
© 2025 GZERO Media. All Rights Reserved | A Eurasia Group media company.